Answers are grounded in this paper and cite their sources.
The in vivo intergenus gene transfer of OXA-48 in the gut of an infected patient was verified in vitro and in 2 in vivo models, which both showed even higher transmission frequencies vs in vitro conditions. This implies that the current in vitro protocols might not correctly reflect the HGT of carbapenemase genes in vivo.
No takes yet. Share an insight, caveat, or question.
Göttig et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: